The US Food and Drug Administration on 23 September granted emergency use authorization (EUA) to Assure Tech Co. Ltd. for its point-of-care serology test for COVID-19. It’s the first POC blood test for determining whether a person has been exposed to the SARS-CoV-2 virus.
The Assure COVID-19 IgG/IgM Rapid Test Device – originally issued an EUA in July for use only in labs – requires a fingerstick to draw blood. With the fresh EUA,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?